Any site that administers the currently authorized vaccines must be prepared to recognize and treat a severe allergic reaction that may occur, though it is “a rare outcome,” federal health officials said.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Congressman calls for FDA to continue vaccine trials
ABC, December 29, 2020. Rep. Llyod Doggett of Texas wrote to the FDA urging COVID-19 clinical trials to continue until they have more data.
Read More »Covid-19: Should vaccine trials be unblinded?
BMJ, December 29, 2020. Volunteers in COVID-19 vaccine studies want the vaccine, not placebos, but stopping studies early could be dangerous.
Read More »How Effective Is the Mask You’re Wearing? You May Know Soon
A CDC division is working with an industry standards group to develop filtration standards — and products that meet them will be able to carry labels saying so.
Read More »FDA Panel Reviewing Pfizer Vaccine Leaves Out Some Experts Who Raised Concerns
POGO, December 9, 2020. FDA’s coronavirus vaccine panel did not include experts who raised concerns about Pfizer’s data at a previous meeting.
Read More »